Has Jodi Cardinale, PA received payments from drug or device companies?

Yes. Drug and device makers reported $2,430 in general payments to Jodi Cardinale, PA across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jodi Cardinale, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jodi Cardinale, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jodi Cardinale, PA

Medical · Corning, NYNPI 1487739504

Payments from drug & device makers

$2,430in general payments, 2019–2025

Across 83 payments — averaging $29.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
AbbVie$1K
Exact Sciences$113
Novo Nordisk$105
Pfizer$30

What the payments were for

Food & beverage$2,430100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	22	$1,118
AbbVie	48	$1,065
Exact Sciences	5	$113
Novo Nordisk	6	$105
Pfizer	2	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FARXIGA$514
AIRSUPRA$218

How this compares

$2,430 in reported general payments places this provider in the 80th percentile of 2,395 medical providers in New York.

See all medical providers in New York →

Medicare billing

Part B allowed, 2024

$74,362

Medicare patients

296

Services billed

2,978

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	116	$140,314
EliquisApixaban	67	$89,584
JardianceEmpagliflozin	57	$74,688
MounjaroTirzepatide	54	$60,122
FarxigaDapagliflozin Propanediol	39	$52,689
XareltoRivaroxaban	46	$45,373
RybelsusSemaglutide	18	$33,578
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	37	$33,036
LinzessLinaclotide	32	$31,807
TrulicityDulaglutide	24	$30,507
GraliseGabapentin	15	$28,388
MyrbetriqMirabegron	28	$20,254
NucyntaTapentadol Hcl	22	$18,336
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	25	$17,370
Spiriva HandihalerTiotropium Bromide	16	$13,460

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic, Rybelsus	$105	$173,893134 claims
PfizerEliquis	$30	$89,58467 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort	$1,118	$73,97891 claims
AbbVieLinzess	$1,065	$31,80732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,395 medical providers in New York.

Other medical in Corning

Rebecca EllwoodAlbany$565K
Denisse SerranoCortlandt Manor$255K
Michele Kissous-HuntNew York$246K
Laura MaroldoNew York$126K
Carl ClarkeBrooklyn$116K
Maureen ThyneNew York$109K
Gina FriesRochester$106K
Ilse StraussSmithtown$87K
Helen AdamsNew York$87K
Hailey BrickmanNew York$82K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →